
Jane Rhodes brings extensive experience in novel biotechnology development to her role as USP At-Large Trustee. Her expertise will help inform USP’s strategy as it continues to prioritize the development of state-of-the-art solutions to accelerate the advancement of innovative therapeutics.
In leadership roles with numerous life sciences organizations, Jane has driven significant innovations in drug discovery and personalized medicine for more than two decades. She is currently serving as the CEO of AstronauTx Ltd, a company dedicated to combating Alzheimer’s disease. She co-founded Qr8 Health, which develops digital tools for clinical data collections, along with ten years of professional experience in multiple roles at Biogen.
Jane’s impact extends globally, particularly in low- and middle-income countries. As an advocate for REACH for Uganda, she has contributed to education, healthcare, and development in rural communities, significantly improving lives through her fundraising and volunteer efforts. Jane also has been a devoted leader in advancing opportunities for women in biotechnology through her participation in mentoring programs and related initiatives.
Career Highlights:
- AstronauTx Ltd: CEO & Board member
- Verge Genomics: President & Chief Business Officer
- FORMA Therapeutics: Vice President, Business Development and Corporate Strategy
- Biogen: Senior Director, New Initiatives Innovation Hub; Program Director, Research Scientist, various other positions
Education:
- B.Sc. Joint Honors Degree Pharmacology & Physiology, University of Manchester, UK
- Ph.D., Neuroscience, University of Manchester, UK
- MBA, Babson College, Olin Business School, USA
Awards, Recognition, Admissions:
- Board Member, Audit Committee, AstronauTx
- Chairperson, Pheno Therapeutics
- Non-Executive Director, Turbine AI
- Member, Compensation Committee, Verge Genomics
- Co-founder and Board Observer, Qr8 Health
Professional Achievements
- Over 40 peer-reviewed publications in scientific journals, plus book chapters and review articles largely focused on drug discovery and development of novel therapies for neurological diseases.
- Inventorship on over a dozen patents, filed and granted across multiple geographies, encompassing composition of matter, methods of use, research tools and software as a medical device.
- Supporter of STEM initiatives and career development for early career scientists and students interested in careers in biotechnology, particularly women.
- REACH for Uganda advocate & education sponsor (2013-present), Development Committee Member (2015-2020) (formerly Arlington Academy of Hope).
